In order to provide you with a better browsing experience and to improve our site functionality, we use cookies and other tracking technologies. Detailed information on the use of cookies on our site and how to opt out is provided in our Cookie Policy. By clicking into any content on this site, you consent that we can store and access cookies and other tracking technologies as described in our Cookie Policy.

Philippines
News Release

May 2, 2024

Fujifilm Philippines supports campaign to end TB

Fujifilm Philippines, a global leader in imaging and healthcare technology, has expressed support for the Department of Health (DOH) and United States Agency for International Development (USAID) in their campaign to end tuberculosis (TB) in the country. 2022 data from the DOH show that around 106 Filipinos die every day from TB, a severe lung infection caused by bacteria.

Fujifilm Philippines is dedicated to the fight to end TB by introducing cutting-edge technologies and innovations. One of the critical contributions Fujifilm has made is providing FDR Xair, a portable X-ray system. This innovative device plays a crucial role in early TB detection by enabling healthcare professionals to conduct rapid and accurate screenings in diverse settings. By deploying portable X-ray systems in areas across the country, Fujifilm is helping bridge healthcare access gaps and improve diagnostic capabilities.

The FDR Xair, well-known for its portability and high image quality, plays a pivotal role in enhancing TB screening efforts, particularly in remote and underserved communities where access to healthcare infrastructure is limited. The FDR Xair, with its portable design and advanced imaging technology, revolutionizes TB screening in remote areas by providing reliable performance, ease of use, and data- driven approaches to TB control.

Fujifilm’s innovative solutions align with the efforts of USAID’s TB Innovations and Health Systems Strengthening project, implemented by FHI 360, to reach, cure, and prevent TB in the country using a whole-of-government approach.

Fujifilm Philippines conducted their first Medical Mission and TB screening using their x-ray systems (FDR nano and FDR Go PLUS) in Majayjay Laguna in 2023. The company plans to continue this program annually and utilize FDR Xair. By working closely with affected communities, local healthcare providers, and grassroots organizations, the company ensures that TB interventions are culturally sensitive, equitable, and sustainable.

In light of the global challenge posed by TB, Fujifilm recognizes the necessity of a coordinated, multi-sectoral approach. The company stands in solidarity with governments, international organizations, civil society, and the private sector to tackle TB head-on, with the shared goal of building a healthier, TB-free future.

Fujifilm Philippines recognizes the urgent need to enhance TB detection capabilities as cases of this infectious disease continue to surge across the country, according to the DOH.As of December 31, 2023, DOH recorded over 600,000 cases of TB, or 549 cases per 100,000 people. This figure is higher than that of 2022, with 439 cases per 100,000 people. Despite its lethality, TB can be cured through free medication provided at TB DOTS clinics nationwide, where patients undergo a six-month treatment regimen without interruption.

Photo

Caption

image

L-R: Mr. Takashi Miyako (Vice President of FUJIFILM Philippines Inc. & General Manager of Medical Division) and Mr. Masahiro Uehara (President of FUJIFILM Philippines Inc.)